Eman A. Mazyed
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
-
- Advancements in Transdermal Drug Delivery 10
- Advanced Drug Delivery Systems 7
- Drug Solubulity and Delivery Systems 5
- Co-authors
- Farid A. Badria (6 shared papers)Amira H. Hassan (1 shared paper)Abdullah A. Elgazar (1 shared paper)Nemany A. N. Hanafy (1 shared paper)Galal Magdy (2 shared papers)Engy Elekhnawy (1 shared paper)Fardous F. El‐Senduny (2 shared papers)Assem Barakat (2 shared papers)
- Journals
- Pharmaceutics (4 papers)Journal of Drug Delivery Science and Technology (3 papers)Scientific Reports (2 papers)Drug Delivery and Translational Research (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- EgyptSaudi ArabiaNetherlands
In The Last Decade
Eman A. Mazyed
17 papers receiving 378 citations
Peers
Comparison fields: 5 of 70
- Pharmaceutical Science 187
- Molecular Medicine 23
- Biomaterials 60
- Dermatology 27
- Complementary and alternative medicine 21
Countries citing papers authored by Eman A. Mazyed
This map shows the geographic impact of Eman A. Mazyed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman A. Mazyed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman A. Mazyed more than expected).
Fields of papers citing papers by Eman A. Mazyed
This network shows the impact of papers produced by Eman A. Mazyed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman A. Mazyed. The network helps show where Eman A. Mazyed may publish in the future.
Co-authors
The 19 scholars most cited alongside Eman A. Mazyed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 83 | |
| 2 | 2021 | 66 | |
| 3 | 2020 | 51 | |
| 4 | 2020 | 39 | |
| 5 | 2020 | 30 | |
| 6 | 2019 | 26 | |
| 7 | 2023 | 19 | |
| 8 | 2022 | 18 | |
| 9 | 2022 | 18 | |
| 10 | 2024 | 11 | |
| 11 | 2024 | 7 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 |
About Eman A. Mazyed
Eman A. Mazyed is a scholar working on Pharmaceutical Science, Molecular Biology, Dermatology, Pharmacology and Oncology, having authored 18 papers that have together received 382 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (10 papers), Advanced Drug Delivery Systems (7 papers), Drug Solubulity and Delivery Systems (5 papers), Analytical Methods in Pharmaceuticals (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer-related Molecular Pathways (2 papers), Dermatology and Skin Diseases (2 papers) and Facial Rejuvenation and Surgery Techniques (1 paper). The work is most often cited by research in Pharmaceutical Science (187 citations), Molecular Medicine (23 citations), Biomaterials (60 citations), Dermatology (27 citations) and Complementary and alternative medicine (21 citations). Eman A. Mazyed has collaborated with scholars based in Egypt, Saudi Arabia and Netherlands. Frequent co-authors include Farid A. Badria, Amira H. Hassan, Abdullah A. Elgazar, Nemany A. N. Hanafy, Galal Magdy, Engy Elekhnawy, Fardous F. El‐Senduny, Assem Barakat, Abdullah Mohammed Al‐Majid and Marwa M. Abu‐Serie. Their work appears in journals such as Pharmaceutics, Journal of Drug Delivery Science and Technology, Scientific Reports, Drug Delivery and Translational Research and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.